Urovant Sciences Ltd. Gains 93.48%

Urovant Sciences Ltd. (UROV:NASDAQ) rocketted at $16.02, a gain of 93.5%. On Thu 12 Nov 20, UROV:NASDAQ touched a New 2-Week Intraday High of $8.33. The stock got featured on our News Catalysts scanner on Fri 13 Nov 20 at 03:54 PM in the 'INVESTOR UPDATE' category. From Thu 29 Oct 20, the stock recorded 60.00% Up Days and 45.45% Green Days

The share price of the company has been moving sideways in recent weeks.

About Urovant Sciences Ltd. (UROV:NASDAQ)

Urovant Sciences Ltd is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing therapies for urologic conditions. The company's pipeline products include Overactive Bladder (OAB), OAB in Men with Benign Prostatic Hyperplasia (BPH), and IBS-Associated Pain.